As other sectors stumble, health care stocks are finally hitting new all-time highs again after 2 long years The concept of rotational leadership, in which…

As other sectors stumble, health care stocks are finally hitting new all-time highs again after 2 long years The concept of rotational leadership, in which…
The frightful performance of the health care sector could find imminent relief at a key chart juncture – if temporarily. If there is one sector…
A key gauge of biotechnology stocks is testing major trendline support presently – can it hold yet again? When this market cycle finally comes to…
The bruised and bloodied Biotech sector is testing a trendline that may determine whether it has one more bull bounce – or if its bubble…
A key index of biotechnology stocks may be approaching significant levels of resistance. Throughout the course of the post-February rally, one topic that has been…
This post originally appeared as the J.Lyons Fund Management, Inc. December 2015 Newsletter at jlfmi.com. As we wrap up 2015, we again pause to reflect on…
Pullback in Margin Debt is healthy…unless it signifies the start of a larger decline. In our post yesterday on household stock investment, we discussed what…
If there must be a poster child for the 6-year cyclical bull market, it is likely the biotech sector. At least that is certainly true…
While the post-2009 cyclical bull market has yet to run its course, there is a clear leader in the clubhouse in the race for poster…
The topic of margin debt always seems to be the source of much debate by market observers. Folks seem to fall on one of two…